Core clinical engineering and protocols for FDA 510(k) Substantial Equivalence.
Over 80% of clinical AI software cleared in the United States utilizes the FDA 510(k) pathway, demonstrating that the device is 'substantially equivalent' in safety and effectiveness to a legally marketed predicate device. MedicalSoftwareAI provides structured templates and automated comparison engines that map algorithmic performance metrics directly against cleared predicates.
To satisfy FDA expectations, diagnostic AI must undergo Multi-Reader Multi-Case clinical testing: evaluating whether radiologists assisted by AI achieve statistically significant improvements in sensitivity or workflow efficiency compared to unassisted review. We outline protocols for statistical sample size calculation and non-inferiority trials.